2N7-13822-43600
2 vaccinations
2 coded responses
21 check-ins
1 free-text entry
3 call cases
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 801 / CO
- Registered
- 2022-11-16
- Relationship
- Child or adolescent in my care
- Guardian
- ZLF-13941-46352
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-11-15
Dose 1 — Pfizer-BioNTechCo-administered: Flu
-
2022-11-16
Registered in v-safe
-
2022-11-16
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Fair · Site: Pain · Fever · Irritability/crying · Be unable to work or attend schoolUnder 3 check-in
-
2022-11-17
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Poor · Fever · Sleepiness, Irritability/crying, Loss of appetite · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationUnder 3 check-in
-
2022-11-17
Report sent to call center — days 1–6 daily, dose 1, under 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-11-18
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Fair · Fever · Irritability/crying, Loss of appetite · Be unable to work or attend schoolUnder 3 check-in
- 2022-11-18
-
2022-11-19
Survey response — days 1–6 daily, dose 1, under 3MedDRA: Ear infection, Office visit — Feeling: Poor · Site: Pain · Fever · Sleepiness, Irritability/crying, Loss of appetite · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Systemic reaction (other): Ear infection · Healthcare visit (other): Sick visit with pediatricianMedDRA releases: 2024-11 · check-in free text available
-
2022-11-19
Report sent to call center — days 1–6 daily, dose 1, under 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
-
2022-11-20
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Fair · Site: Pain · Irritability/cryingUnder 3 check-in
- 2022-11-21
-
2022-11-21
Call successfulParticipant prefers to complete VAERS report online
-
2022-11-21
Call successfulParticipant prefers to complete VAERS report online
- 2022-11-22
- 2022-11-29
- 2022-12-06
-
2022-12-08
Dose 2 — Pfizer-BioNTech
-
2022-12-09
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Fair · Site: Pain · Irritability/crying, DiarrheaUnder 3 check-in
-
2022-12-10
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Fair · Irritability/cryingUnder 3 check-in
- 2022-12-12
- 2022-12-13
- 2022-12-14
- 2022-12-15
- 2022-12-22
- 2022-12-31
- 2023-01-05
- 2023-01-12
-
2023-01-19
Survey response — day 42, dose 2, under 3MedDRA: Decreased appetite, Vomiting — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationMedDRA releases: 2024-11
-
2023-01-19
Report sent to call center — day 42, dose 2, under 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2023-01-20
- 2023-03-09
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-11-15 | Pfizer-BioNTech | Flu |
| 2 | 2022-12-08 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-11-17 | Successful 2022-11-21 |
Participant prefers to complete VAERS report online |
| 2022-11-19 | Successful 2022-11-21 |
Participant prefers to complete VAERS report online |
| 2023-01-19 | Unsuccessful |
Free text
Release 12 (Under 3) — days 1–6 daily, dose 1, under 3
Systemic reaction (other): Ear infection
Healthcare visit (other): Sick visit with pediatrician
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Decreased appetite | · | · | ✓ |
| SD | Vomiting | · | · | ✓ |
| SRO | Ear infection | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release